Tailored, earlier cardiac rehab program shows physical, emotional benefits for heart failure patients
AAKP Patient Impact Statement: FDA APPROVAL OF KERENDIA TO HELP SLOW KIDNEY DISEASE AND FAILURE ASSOCIATED WITH TYPE 2 DIABETES
Coming Soon: PCD Collection on Health Disparities and Position Statement on Diversity, Equity, and Inclusion